Alnylam® Pharmaceuticals

Jan 17, 2019

Patisiran for the Treatment of Hereditary Transthyretin-Mediated Amyloidosis

Hereditary transthyretin-mediated amyloidosis is caused by a mutation in transthyretin (TTR) gene resulting in misfolded TTR protein accumulating as amyloid fibrils…